JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 1 October 2007. doi:10.1136/jcp.2007.050666
Journal of Clinical Pathology 2008;61:658-664
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcp.2007.050666v1
61/5/658    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chai, C-Y
Right arrow Articles by Yang, C-H
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chai, C-Y
Right arrow Articles by Yang, C-H

ORIGINAL ARTICLES

Hypoxia-inducible factor-1{alpha} expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma

C-Y Chai1, W-T Chen2, W-C Hung3, W-Y Kang1,2, Y-C Huang4, Y-C Su2, C-H Yang2

1 Department of Pathology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
2 Department of Pathology, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
3 Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan
4 Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

Correspondence to:
C-Y Chai, Department of Pathology, Kaohsiung Medical University Chung-Ho Memorial Hospital, No. 100, Tzyou 1st Road, Kaohsiung City 807, Taiwan; cychai{at}kmu.edu.tw

Background: Hypoxia inducible factor (HIF)-1{alpha} is a critical regulatory protein of cellular response to hypoxia and is closely related to angiogenic process.

Aims: To explore the potential role and the prognostic value of HIF-1{alpha} in urothelial carcinoma (UC).

Methods: Clinicopathological and follow-up data on 99 UC cases were reviewed and immunostained for HIF-1{alpha}, CD68, vascular endothelial growth factor (VEGF) and CD34 antigen. Tumour-associated macrophage (TAM) counts and HIF-1{alpha} expression were compared with clinicopathologic characteristics, overall survival (OS) and disease-free survival rates (DFS).

Results: High expression of HIF-1{alpha} was detected in 55 of 99 (55.6%) tumours. HIF-1{alpha} expression was correlated with tumour size, histological grade, tumour invasiveness and recurrence. VEGF and microvessel density (MVD) demonstrated their positive correlation with HIF-1{alpha} overexpression, supporting the correlation of HIF-1{alpha} up-regulation with tumour angiogenesis. Higher TAM infiltration was identified in high expression of HIF-1{alpha} cases rather than HIF-1{alpha} low expression cases (p = 0.002). Kaplan–Meier analysis found that HIF-1{alpha} overexpression and high TAM count was only associated with worse DFS (p = 0.009, p = 0.023) but was not associated with OS (p = 0.696, p = 0.141). Multivariate analyses indicated only tumour size (p = 0.038) to be an independently significant prognostic factor for OS, in addition, HIF-1{alpha} expression (p = 0.011), as well as histological grade (p = 0.038), and MVD (p = 0.004), to be independently significant prognostic factors for DFS.

Conclusions: Our results indicate that HIF-1{alpha} is a key regulator of the angiogenic cascade. We show that HIF-1{alpha} is an independent prognostic factor for disease-free survival.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.